GB Patent

GB2121401A — Teichomycin a2 pure single factors1 2 3 4 and 5 and method for their production

Assigned to Gruppo Lepetit SpA · Expires 1983-12-21 · 42y expired

What this patent protects

Patent listed against dalbavancin-hydrochloride.

Drugs covered by this patent

dalbavancin-hydrochloride (DALBAVANCIN HYDROCHLORIDE)

Patent Metadata

Patent number: GB2121401A
Jurisdiction: GB
Classification: —
Expires: 1983-12-21
Drug substance claim: No
Drug product claim: No
Assignee: Gruppo Lepetit SpA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.